Our studies of Levantine viper venom have demonstrated that the venom is a rich source of biomedically important proteins and peptides. The venom contains metalloproteases: thrombolytic, fibrin-degrading lebetase, an endothelial cell apoptosis inducing metalloprotease (VLAIP), factor X activator (VLFXA); serine proteases: factor V activator, bradykininreleasing serine proteases, β-fibrinogenase, α-fibrinogenase and chymotrypsin-like protease and different other enzymes such as phosphodiesterase, 5`-nucleotidase, ribonuclease, phospholipase A2s and L-amino acid oxidase. Among nonenzymatic components venom contains: nerve growth factor, vascular endothelial growth factor, disintegrins, C-type lectins.
Introduction
Snake venoms are complex mixtures of pharmacologically active proteins and peptides. They can target different tissues, causing simultaneous changes of multiple physiological systems and, therefore, snake venom components may be useful candidates for therapeutic agents, for use in the diagnosis of several diseases and for understanding physiological and pathological processes in basic research. Our studies of Levantine viper venom have demonstrated that the venom is rich source of biomedically important proteins (e.g. factor V and X activators, fibrinolytic enzyme, disintegrins). The venom contains metalloproteases that all have a typical zinc chelating sequence (HEXXHGXXH) [1] : thrombolytic fibrin-degrading lebetase [2] , an endothelial cell apoptosis inducing metalloprotease (VLAIP) [3] , factor X activator (VLFXA) [4] . V. lebetina venom contains also different serine proteases: factor V activator (VLFVA) [5] , bradykinin-releasing serine proteases, thermostable β-fibrinogenase, α-fibrinogenase (VLAF) [6] and chymotrypsin-like protease (VLCTLP) which has no homolog among known serine proteases. L-amino acid oxidase (LAAO) [7] and phospholipase A2s (VLPLA2) [8] besides their specific enzymatic activity inhibit platelet aggregation induced by ADP or collagen. Among nonenzymatic components venom contains nerve growth factor (NGF) [9] , vascular endothelial growth factor (VEGF) [10] , disintegrins [11] [12] [13] [14] [15] [16] , C-type lectins [17] .
Here we provide the complex block-scheme of the isolation and characterization of above mentioned proteins and peptides from Vipera lebetina venom using size exclusion, ion exchange, hydrophobic and affinity chromatographies, HPLC, UPLC, LC-ESI-MS/MS and MALDI-TOF MS methods.
Methods
Protease activities were determined with azocasein and fibrinogen as substrates [18] . Fibrinolytic activity was assayed by fibrin plate technique [19] . Esterolytic activities were determined using ATEE and BAEE as substrates [20] . Phospholipase A 2 activity was assayed by titrametric method using egg yolk phosphatidylcholine as a substrate [8] . LAAO activity was determined spectrophotometrically using the method modified from Bergmeyer [21] . Proteins and peptides were purified from crude V. lebetina venom (Tashkent Serpentarium, Uzbekistan) using the different purification schemes. The size exclusion, ion exchange, HPLC, UPLC and affinity columns were commercial. Purified proteins and peptides were analysed by SDS-PAGE, isoelectric focusing and MALDI-TOF MS. Fibrinogen degradation products were analysed by SDS-PAGE. N-terminal sequences and internal sequences of tryptic peptides of different purified proteins were determined using Edman sequencing and LC MS/MS technique. MALDI-TOF mass spectrometry analysis was used for the recovery and identification of the peptides released by trypsin hydrolysis using 2,5-dihydroxybenzoic acid as matrix. The MALDI-TOF mass spectra were measured with a home-built MALDI mass spectrometer designed for maximum flexibility in use [22] . All peptides were synthesized at the 100 µmol scale on Applied Biosystems 431A Peptide Synthesizer using BOC (t-butyloxycarbonyl) chemistry as suggested by the manufacturer. The purity of peptides was assessed by HPLC and MALDI-TOF mass spectrometry. Platelet aggregation assays were performed in human platelet-rich plasma using a Chronolog aggregometer [18] . For detection of the NGF bioactivity, in vitro bioassay with rat PC12 pheochromocytoma cells (ATCC CRL-1721, USA) was used [23] . The cDNA library of the venom gland of a single adult Central Asian Vipera lebetina snake was constructed in the Uni-ZAP XR [24] and was used as a source of the template. PCR was carried out in a Perkin Elmer Thermal Cycler 480. The clones were sequenced on Perkin Elmer ABI Prism Model 310 DNA Sequencer by cycle sequencing using ABI Prism Dye Terminator Cycle Sequencing Ready Reaction Kit with AmpliTaq DNA Polymerase.
Results

Purification of venom components
For the first step of purification size-exclusion chromatography on Sephadex G-100sf column in the soft conditions (eluent: 0.2 M ammonium acetate) was used saving biological activities of venom components (Fig. 1) . The first fraction contains VLFXA, VLAIP, nucleotidases, phosphodiesterase, L-amino acid oxidase and several unidentified components. β-Fibrinogenase, chymotrypsin-like protease (VLCTLP) and hyaluronidase are between the first and the second fraction. Factor V activator, α-fibrinogenase, nerve growth factor, vascular endothelial growth factor, dimeric disintegrins, phospholipase A 2 , C-type lectins are eluted in the second fraction. Lebetase isoforms are in the third fraction. The low-molecular mass fractions (IV and V) contain several peptides. The individual proteins were obtained by combining different separation methods (Fig. 2) . Here only a simplified block-scheme is presented; the detailed purifications of different proteins and peptides are described in our previous publications [3, 5, 7-9, 11, 25, 26] . VEGF [10] , lebein [12] , lebestatin [13] , C-type lectins [17] are purified and characterized in other laboratories. Here these components were localized in size exclusion chromatography fractions (Fig. 2) by tryptic peptide fragments using MALDI-TOF MS and the primary structure data provided in databases. 
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Size-exclusion chromatography on Sephadex G-100sf of Vipera lebetina venom Fig. 2 . The block-scheme of separation of proteins and peptides from Vipera lebetina venom. The detailed purification conditions are described in our previous publications: LAAO [7] , VLAIP [3] , VLFXA [25] , VLFVA [5] , NGF [9] , viplebedin-2 [11] , VLPLA 2 [8] , lebetase [26] . Size-exclusion chromatography -green boxes; ionexchange chromatography -blue boxes; HPLC and UPLC -pink boxes; affinity chromatography -yellow boxes.
Specificity studies of proteases
MALDI-TOF mass spectrometry technique was used for the discovery and identification of peptides released by protease hydrolysis (Fig. 3A,B; Fig. 4 A,B) . The activity of snake venom proteases against bradykinin, substance P, insulin B-chain and 6-10 amino acid residues containing peptides synthesized according to potential cleavage regions of fibrinogen, factor X, factor IX, factor V, α2-macroglobulin bait region and pregnancy zone protein (PZP) was examined. Lebetase and VLAIP cleavage sites in different peptides are presented in Table 1 . Thrombolytic enzyme lebetase cleaves bradykinin at the position Pro 7 -Phe 8 , as well as the other metalloprotease VLAIP does ( Table 1) . Cleavage of bradykinin by lebetase (an important side effect of the enzyme) destroys its biological activity. Viperidae venoms contain several serine proteases that release bradykinin and metalloproteases that cleave bradykinin, therefore the detection of bradykinin-releasing enzymes without metalloprotease inhibitors in crude venom is inadequate.
Insulin B chain is widely used for specificity studies of different proteases: Ala 14 1) . The sensitive and quick MALDI-TOF mass spectrometry methodology allows us to obtain the primary information about the substrate specificity of different proteases against various peptides and proteins. 
Structural studies
N-terminal sequences and internal sequences of tryptic peptides of purified proteins were determined using Edman sequencing and LC MS/MS technique. On the basis of fragmental sequences of proteins the oligonucleotides were designed and were used as primers for cDNA cloning. Using cDNA library of the venom gland of a single V. lebetina snake the proteins coding cDNAs were cloned and sequenced. The protein sequences were deduced from cDNA sequences. The deduced protein sequences are registered under following accession numbers: lebetases CAA66471; AAY45880; VLFXA chains: AAQ17467; AAQ17468; AAT91068; VLAIP chains: AAX38181; AAX38182; VLFVA AAF03233; VLAF AAM96674; VLPLA 2 s: ACQ57801; ACB59359; disintegrins: ABC18317; ABC00778; NGF AAV64846. Vipera lebetina venom contains all types of reprolysins -metalloproteases that all have a typical zinc chelating sequence (HEXXHGXXH) [1] and monomeric and dimeric disintegrins that are studied by different research groups [11] [12] [13] [14] [15] [16] . Better knowledge of the structural features of venom proteins allows us to consider the use of snake venom components as models for therapeutic agents and as tools in biochemical research to study cellular processes.
Conclusions
• Biomedically important proteins and peptides (VLFXA and VLFVA are diagnostic agents; lebetase is an effective fibrinolytic enzyme; VLAIP is an apoptosis inducing metalloproteinase; disintegrins are potential anticancer agents; growth factors NGF and VEGF; antimicrobial LAAO; platelet aggregation inhibiting PLA2s) were isolated from Vipera lebetina venom using size exclusion, ion exchange, hydrophobic interaction and affinity chromatography, HPLC and UPLC methods.
• A new serine protease from V. Lebetina venom having ChymoTrypsin Like Proteolytic activity (VLCTLP) was purified and characterized. It is the only known enzyme from snake venoms that catalyses acetyltyrosine ethyl ester hydrolysis.
• MALDI-TOF MS is effective tool for detection of protein and peptide molecular masses and for studying of proteolysis degradation products.
